Discover 1,711 paid clinical trials in Bloomfield Hills, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,711
BoxX-NoAF Clinical Trial
for
Post Operative Atrial Fibrillation,
Location: Ypsilanti MI, Ann Arbor MI, Toledo OH, London,
Sponsor: AtriCure, Inc.
Sex: All
Age: 65+
Code: NCT06989775
Recruiting
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
for
Breast Cancer, TNBC - Triple-Negative Breast Cancer,
Location: Ann Arbor MI, Goshen IN, Cincinnati OH, La Crosse WI,
Sponsor: Tempus AI
Sex: All
Age: 18 - 70+
Code: NCT07211178
Recruiting
Multi-Center Study of Clinical and Inflammatory Outcomes in Intensive Cardiac Rehabilitation and Traditional Cardiac Rehabilitation Programs
for
Cardiovascular Diseases
Location: Ypsilanti MI, Asheville NC
Sponsor: Pritikin ICR
Sex: All
Age: 18+
Code: NCT06424119
Recruiting
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
for
HR+/HER2-negative Breast Cancer, Metastatic Breast Cancer
Location: Ypsilanti MI, Cleveland OH, Hinsdale IL, Hershey PA,
Sponsor: SynDevRx, Inc.
Sex: All
Age: 18+
Code: NCT05455619
Phase 1, Phase 2, Recruiting
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Ann Arbor MI, London, Toronto, Pittsburgh PA, Niles IL,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06129864
Phase 3, Recruiting
CtDNA Based MRD Testing for NAC Monitoring in TNBC
for
TNBC - Triple-Negative Breast Cancer, Minimal Residual Disease
Location: Ypsilanti MI, Peoria IL, York PA, Washington DC DC,
Sponsor: Personalis Inc.
Sex: Female
Age: 18+
Code: NCT06230185
Recruiting
Pompe Disease Registry Protocol
for
Glycogen Storage Disease Type II, Pompe Disease
Location: Detroit MI, Ann Arbor MI, London, Cleveland OH,
Sponsor: Genzyme, a Sanofi Company
Sex: All
Age: 0+
Code: NCT00231400
Recruiting
A Study of ASP3082 in Adults With Advanced Solid Tumors